CGTX - Cognition Therapeutics GAAP EPS of -$0.25 beats by $0.07 August, 09 2022 07:27 AM Cognition Therapeutics Inc. Cognition Therapeutics press release ( NASDAQ: CGTX ): Q2 GAAP EPS of -$0.25 beats by $0.07 . Cash and cash equivalents on Q2 was approximately $45.8 million. For further details see: Cognition Therapeutics GAAP EPS of -$0.25 beats by $0.07